Guía de práctica clínica mexicana para el diagnóstico y tratamiento de las dislipidemias y enfermedad cardiovascular aterosclerótica



Título del documento: Guía de práctica clínica mexicana para el diagnóstico y tratamiento de las dislipidemias y enfermedad cardiovascular aterosclerótica
Revista: Archivos de cardiología de México
Base de datos:
Número de sistema: 000541412
ISSN: 1405-9940
Autores: 1
1
3
4
6
3
7
8
6
8
9
1
1
11
10
13
8
6
14
13
15
1
16
9
1
1
1
1
1
3
12
12
3
8
19
20
5
4
5
5
5
20
Instituciones: 1Sociedad Mexicana de Cardiología, Ciudad de México. México
2Universidad Autónoma de Querétaro, Facultad de Medicina, Querétaro. México
3Asociación Nacional de Cardiólogos de México, Ciudad de México. México
4Universidad Nacional Autónoma de México, Facultad de Medicina, Ciudad de México. México
5Instituto Nacional de Pediatría, Secretaría de Salud, Ciudad de México. México
6Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México. México
7Comité Normativo Nacional de Medicina General, Ciudad de México. México
8Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Ciudad de México. México
9Colegio de Medicina Interna de México, Ciudad de México. México
10Asociación Mexicana para la Prevención de la Aterosclerosis y sus Complicaciones, Ciudad de México. México
11Sociedad Mexicana de Nutrición y Endocrinología, Ciudad de México. México
12Colegio Nacional de Medicina Geriátrica, Ciudad de México. México
13Academia Mexicana de Neurología, Ciudad de México. México
14Instituto Mexicano de Investigaciones Nefrológicas, Ciudad de México. México
15University of Miami, Departamento de Salud Pública, Miami, Florida. Estados Unidos
16Sociedad Mexicana de Angiología Cirugía Vascular y Endovascular, Ciudad de México. México
17Instituto Mexicano del Seguro Social, Ciudad de México. México
18Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Ciudad de México. México
19Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XX, Ciudad de México. México
20Ibero American Agency for Development & Assessment of Health Technologies, Ciudad de México. México
Año:
Periodo: Mar
Volumen: 92
Paginación: 1-62
País: México
Idioma: Español
Resumen en español resumen está disponible en el texto completo
Resumen en inglés Background: Cardiovascular diseases are the leading cause of mortality worldwide and Mexico is no exception. The epidemiological data obtained in 1990 showed that cardiovascular diseases represented 19.8% of all causes of death in our country. This figure increased significantly to 25.5% for 2015. Some national surveys suggest that more than 60% of the adult population has at least one risk factor for cardiovascular disease (obesity or overweight, hypertension, smoking, diabetes, dyslipidemias). On the other hand, data from the Pan American Health Organization have linked the process of atherosclerosis as the first cause of premature death, significantly reducing life expectancy, which has enormous social repercussions. Objective: This document constitutes the Clinical Practice Guide (CPG) prepared at the initiative of the Mexican Society of Cardiology in collaboration with the Mexican Society of Nutrition and Endocrinology, AC, National Association of Cardiologists of Mexico, AC, Mexican Association for the Prevention of Atherosclerosis and its Complications, AC, National Normative Committee of General Medicine, AC, National College of Geriatric Medicine, AC, College of Internal Medicine of Mexico, AC, Mexican Society of Angiology and Vascular and Endovenous Surgery, AC, Mexican Institute of Research Nephrological, AC and the Mexican Academy of Neurology, A.C.; with the methodological support of the Ibero-American Agency for the Development and Evaluation of Health Technologies, in order to establish recommendations based on the best available evidence and agreed upon by an interdisciplinary group of experts. The objective of this document is to provide evidence-based recommendations to help decision makers in the diagnosis and treatment of dyslipidemias in our country. Material and methods: This document complies with international quality standards, such as those described by the Institute of Medicine of the USA, the Institute of Clinical Excellence of Great Britain, the Scottish Intercollegiate Guideline Network and the Guidelines International Network. A multidisciplinary group of clinical experts and methodologists with experience in systematic reviews of the literature and the development of clinical practice guidelines was formed. A scope document was agreed upon, relevant clinical questions were established, the best available evidence critically evaluated in systematic literature reviews was exhaustively identified, and clinical recommendations were developed. The modified Delphi Panel methodology was used to achieve an adequate level of consensus in each of the recommendations contained in this CPG. Results: 23 clinical questions were agreed upon which gave rise to their respective clinical recommendations. Conclusions: We consider that this document contributes to better clinical decision-making and becomes a point of reference for clinicians and patients in the management of dyslipidemias and this contributes to reducing the morbidity and mortality derived from atherosclerotic cardiovascular events in our country.
Palabras clave: Dislipidemias,
Enfermedad cardiovascular,
Enfermedad cardiovascular aterosclerótica,
Guía de práctica clínica,
Revisiones sistemáticas
Keyword: Dyslipidemias,
Cardiovascular disease Atherosclerotic cardiovascular disease,
Clinical practice guide,
Systematic reviews
Texto completo: Texto completo (Ver HTML) Texto completo (Ver PDF)